Close Menu

NEW YORK (GenomeWeb) – German multiomics tools firm Centogene announced today a collaboration with the medical faculties of the Universities of Greifswald and Rostock to develop diagnostic tools for personalized, immune-based treatments for colon and pancreatic tumors.

As part of the research project, Centogene will genetically profile cancer patients to identify immune-relevant mutations and identify specific biomarkers for early differential diagnosis and therapy monitoring.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.